Cargando…
The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
PURPOSE: Evaluation of the neuroprotective effect of weekly glatiramer acetate (GA) on retinal structure and function in diabetic patients who underwent panretinal photocoagulation (PRP). PATIENTS AND METHODS: Patients with severe nonproliferative or early proliferative diabetic retinopathy and no p...
Autores principales: | Mitne, Somaia, Teixeira, Sergio Henrique, Schwartz, Michal, Belkin, Michael, Farah, Michel Eid, de Moraes, Nilva S Bueno, Nóia, Luciana da Cruz, Paes, Ângela Tavares, Lottenberg, Cláudio Luiz, Júnior, Augusto Paranhos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141864/ https://www.ncbi.nlm.nih.gov/pubmed/21792290 http://dx.doi.org/10.2147/OPTH.S22964 |
Ejemplares similares
-
The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis
por: Huang, Chao, et al.
Publicado: (2021) -
Analgesic Effects of Tramadol During Panretinal Photocoagulation
por: Ko, Byoung-Woo, et al.
Publicado: (2009) -
A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
por: Sun, Yaoyao, et al.
Publicado: (2023) -
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
por: Kasindi, Arielle, et al.
Publicado: (2022) -
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial
por: Arnold, Douglas L., et al.
Publicado: (2013)